278 related articles for article (PubMed ID: 2104892)
1. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
Ballas ZK; Rasmussen W
J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
Ballas ZK; Rasmussen W
J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
[TBL] [Abstract][Full Text] [Related]
3. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
Lynch DH; Miller RE
J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells.
Mason LH; Mathieson BJ; Ortaldo JR
J Immunol; 1990 Jul; 145(2):751-9. PubMed ID: 2365999
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer (LAK) cells. VI. NK1.1+, CD3+ LAK effectors are derived from CD4-, CD8-, NK1.1- precursors.
Ballas ZK; Rasmussen W
Cell Immunol; 1991 May; 134(2):296-313. PubMed ID: 1827045
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.
Ballas ZK; Rasmussen W; van Otegham JK
J Immunol; 1987 Mar; 138(5):1647-52. PubMed ID: 2879870
[TBL] [Abstract][Full Text] [Related]
8. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
Basiri H; Kiura K; DeNardin EG; Nakamura I
J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
[TBL] [Abstract][Full Text] [Related]
9. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation.
Thompson RA; Ballas ZK
J Immunol; 1990 Nov; 145(10):3524-31. PubMed ID: 1700014
[TBL] [Abstract][Full Text] [Related]
11. Murine trophoblast can be killed by lymphokine-activated killer cells.
Drake BL; Head JR
J Immunol; 1989 Jul; 143(1):9-14. PubMed ID: 2499634
[TBL] [Abstract][Full Text] [Related]
12. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro.
Kung SK; Miller RG
J Immunol; 1995 Feb; 154(4):1624-33. PubMed ID: 7836747
[TBL] [Abstract][Full Text] [Related]
13. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
Morelli L; Lemieux S
J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
[TBL] [Abstract][Full Text] [Related]
14. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
Karlhofer FM; Yokoyama WM
J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
LeFor AT; Eisenthal A; Rosenberg SA
J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic effector cells: definition and analysis of activity.
Ortaldo JR
Allergol Immunopathol (Madr); 1991; 19(4):145-56. PubMed ID: 1726345
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
20. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
Ellison CA; MacDonald GC; Rector ES; Gartner JG
J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
